Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
5.12
+0.69 (15.58%)
At close: May 13, 2025, 4:00 PM
5.18
+0.06 (1.17%)
Pre-market: May 14, 2025, 8:51 AM EDT

UPC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2018 - 2019
Market Capitalization
2631254-
Upgrade
Market Cap Growth
66.62%66.62%-71.82%-77.13%--
Upgrade
Enterprise Value
-201-19-1220-
Upgrade
Last Close Price
5.12146.40570.002034.008891.99-
Upgrade
PE Ratio
----4.75-
Upgrade
PS Ratio
0.000.250.110.311.12-
Upgrade
PB Ratio
0.000.130.120.270.91-
Upgrade
P/TBV Ratio
0.040.130.120.270.91-
Upgrade
P/FCF Ratio
--3.23---
Upgrade
P/OCF Ratio
--3.10---
Upgrade
EV/Sales Ratio
-0.04--0.43-
Upgrade
EV/EBITDA Ratio
----1.46-
Upgrade
EV/EBIT Ratio
----1.51-
Upgrade
Debt / Equity Ratio
0.180.180.200.090.070.13
Upgrade
Debt / EBITDA Ratio
----0.310.25
Upgrade
Debt / FCF Ratio
--5.11--0.44
Upgrade
Asset Turnover
0.420.420.640.620.971.32
Upgrade
Inventory Turnover
6.676.677.937.8210.377.35
Upgrade
Quick Ratio
2.372.371.332.603.362.62
Upgrade
Current Ratio
2.542.541.843.174.502.91
Upgrade
Return on Equity (ROE)
-23.76%-23.76%-17.69%-15.01%28.39%45.55%
Upgrade
Return on Assets (ROA)
-9.14%-9.14%-4.90%-6.77%17.17%27.47%
Upgrade
Return on Capital (ROIC)
-11.53%-11.53%-5.91%-7.72%19.59%33.41%
Upgrade
Return on Capital Employed (ROCE)
----23.10%49.30%
Upgrade
Earnings Yield
-447.82%-151.27%-190.05%-64.37%21.07%-
Upgrade
FCF Yield
-500.43%-169.04%30.98%-11.35%-29.02%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q